Q3 2025 Earnings Call Transcript November 4, 2025 Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $0.06 EPS, expectations were $0.12. Operator: Good morning, ladies and ...

Initiated PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis ...

Ever since ChatGPT burst onto the scene in 2022, large language models (LLMs) have changed how people make decisions, solve technical issues and even ...

AI in quality assurance (QA) is quietly becoming one of the most powerful tools available to executives. Strong QA does not ...

Duolingo sees strong growth, but AI threats and high valuation raise caution. Explore the outlook, risks, and price target ...

Indonesia’s crypto exchanges warn a proposed law could centralize trading under a state bourse, threatening independent ...

Read Lessons From The CFO on The Wall Street Journal ...

Congress has long recognized that stablecoins should not function as unregulated bank deposits. The intent of the recently ...

Regulated industries like banking, legal, finance, and healthcare face a far greater level of scrutiny when something goes ...

Today, about two-thirds of our direct members have been with Gaia, Inc. for more than a year, and that number continues to grow. This ongoing loyalty strengthens our foundation and positions Gaia, Inc ...

Rhythm Pharmaceuticals will host a live conference call and webcast at 8:00 a.m. ET today to review its third quarter 2025 financial results and recent business activities. Participants may register ...

The administration has found a back-door way to weaken programs it hasn’t eliminated outright. It’s a dangerous precedent.” ...